IBDEI1UL ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,31386,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,31386,1,2,0)
 ;;=2^Clindamycin Phosphate Inj 300mg
 ;;^UTILITY(U,$J,358.3,31386,1,3,0)
 ;;=3^S0077
 ;;^UTILITY(U,$J,358.3,31387,0)
 ;;=J3360^^125^1590^5^^^^1
 ;;^UTILITY(U,$J,358.3,31387,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,31387,1,2,0)
 ;;=2^Diazepam up to 5mg
 ;;^UTILITY(U,$J,358.3,31387,1,3,0)
 ;;=3^J3360
 ;;^UTILITY(U,$J,358.3,31388,0)
 ;;=J1710^^125^1590^6^^^^1
 ;;^UTILITY(U,$J,358.3,31388,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,31388,1,2,0)
 ;;=2^Hydrocortisone Sodium Phosphate Inj up to 50mg
 ;;^UTILITY(U,$J,358.3,31388,1,3,0)
 ;;=3^J1710
 ;;^UTILITY(U,$J,358.3,31389,0)
 ;;=J2550^^125^1590^9^^^^1
 ;;^UTILITY(U,$J,358.3,31389,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,31389,1,2,0)
 ;;=2^Promethazinc HCL Inj up to 50mg
 ;;^UTILITY(U,$J,358.3,31389,1,3,0)
 ;;=3^J2550
 ;;^UTILITY(U,$J,358.3,31390,0)
 ;;=J3301^^125^1590^10^^^^1
 ;;^UTILITY(U,$J,358.3,31390,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,31390,1,2,0)
 ;;=2^Triamcinolone Acetonide per 10mg
 ;;^UTILITY(U,$J,358.3,31390,1,3,0)
 ;;=3^J3301
 ;;^UTILITY(U,$J,358.3,31391,0)
 ;;=J3302^^125^1590^11^^^^1
 ;;^UTILITY(U,$J,358.3,31391,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,31391,1,2,0)
 ;;=2^Triamcinolone Diacetate per 5mg
 ;;^UTILITY(U,$J,358.3,31391,1,3,0)
 ;;=3^J3302
 ;;^UTILITY(U,$J,358.3,31392,0)
 ;;=J3303^^125^1590^12^^^^1
 ;;^UTILITY(U,$J,358.3,31392,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,31392,1,2,0)
 ;;=2^Triamcinolone Hexacetonide per 5mg
 ;;^UTILITY(U,$J,358.3,31392,1,3,0)
 ;;=3^J3303
 ;;^UTILITY(U,$J,358.3,31393,0)
 ;;=J3410^^125^1590^7^^^^1
 ;;^UTILITY(U,$J,358.3,31393,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,31393,1,2,0)
 ;;=2^Hydroxyzine HCL up to 25mg
 ;;^UTILITY(U,$J,358.3,31393,1,3,0)
 ;;=3^J3410
 ;;^UTILITY(U,$J,358.3,31394,0)
 ;;=J1094^^125^1590^4^^^^1
 ;;^UTILITY(U,$J,358.3,31394,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,31394,1,2,0)
 ;;=2^Dexamethasone, per mg
 ;;^UTILITY(U,$J,358.3,31394,1,3,0)
 ;;=3^J1094
 ;;^UTILITY(U,$J,358.3,31395,0)
 ;;=J3490^^125^1590^1^^^^1
 ;;^UTILITY(U,$J,358.3,31395,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,31395,1,2,0)
 ;;=2^Bupivicaine Hcl 1 ml
 ;;^UTILITY(U,$J,358.3,31395,1,3,0)
 ;;=3^J3490
 ;;^UTILITY(U,$J,358.3,31396,0)
 ;;=J3471^^125^1590^8^^^^1
 ;;^UTILITY(U,$J,358.3,31396,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,31396,1,2,0)
 ;;=2^Ovine,Up to 999 USP Units
 ;;^UTILITY(U,$J,358.3,31396,1,3,0)
 ;;=3^J3471
 ;;^UTILITY(U,$J,358.3,31397,0)
 ;;=26535^^125^1591^1^^^^1
 ;;^UTILITY(U,$J,358.3,31397,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,31397,1,2,0)
 ;;=2^Arthroplasty, interphalangeal joint; each joint
 ;;^UTILITY(U,$J,358.3,31397,1,3,0)
 ;;=3^26535
 ;;^UTILITY(U,$J,358.3,31398,0)
 ;;=26536^^125^1591^2^^^^1
 ;;^UTILITY(U,$J,358.3,31398,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,31398,1,2,0)
 ;;=2^Arthroplasty, interphalangeal joint; with prosthetic implant, each jointangeal 
 ;;^UTILITY(U,$J,358.3,31398,1,3,0)
 ;;=3^26536
 ;;^UTILITY(U,$J,358.3,31399,0)
 ;;=27650^^125^1591^15^^^^1
 ;;^UTILITY(U,$J,358.3,31399,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,31399,1,2,0)
 ;;=2^Repair, primary, open or percutaneous, ruptured Achilles tendon
 ;;^UTILITY(U,$J,358.3,31399,1,3,0)
 ;;=3^27650
 ;;^UTILITY(U,$J,358.3,31400,0)
 ;;=27686^^125^1591^7^^^^1
 ;;^UTILITY(U,$J,358.3,31400,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,31400,1,2,0)
 ;;=2^Lengthening or shortening of tendon each, leg or ankle; multiple  tendon
 ;;^UTILITY(U,$J,358.3,31400,1,3,0)
 ;;=3^27686
 ;;^UTILITY(U,$J,358.3,31401,0)
 ;;=27685^^125^1591^8^^^^1
